Abstract
Purpose The purpose of this study was to develop a technique combining video oculography (VOG) with single shot multibox detector (SSD) to accurately and quantitatively examine eye movements.
Methods Eleven healthy volunteers (21.3 ± 0.9 years) participated in this study. Eye movements were recorded while tracking a target using a custom-made eye tracker. The subjects were asked to fixate their focus on the nose of the rabbit-like target (visual angle was 0.1°), which was manually moved to a distance of 1 meter by the examiner during the eye movement test. The test produced 500 images from the VOG external camera and these images were divided into 3 groups (300, 100, and 100) for training, verification, and testing. The performance of the SSD was evaluated with 75% average precision (AP75), and the relationship between the location of the fixated target (calculated by the SSD) and the positions of both eyes (recorded by the VOG) was analyzed.
Results The AP75 of the SSD on one class of targets was 97.7%. The horizontal and vertical target locations significantly and positively correlated with the horizontal and vertical both eye positions (adjusted R2 ≥ 0.955, P < 0.001).
Conclusions Our findings suggest that VOG with SSD is suitable for the evaluation of eye version movements in standard clinical assessments.
Translational Relevance The combination of VOG and SSD can be used to evaluate the SPEM, and this method can be translated into clinical settings without changing the testing methods.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
UMIN000039665
Funding Statement
This work was supported by Grands-in-Aid for Early-Career Scientists, Scientific Research (A) and (B), Challenging Exploratory Research, Japan Society for the Promotion of Science, 19K20728 (MH), 18H04116 (MH), 20K04271 (MH), 19K21783 (MH), and Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder (MH).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of Teikyo University approved the experimental protocol and consent procedures (approval no. 18-161).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author, [MH], upon reasonable request.
